Tesla's Stock Is 28% Overvalued (And It's Not Alone), Analysts Say
Tesla's blowout quarterly profit justifies some of its 260% stock run-up this year. And it also ups the odds the stock will join the S&P 500. But analysts still think Tesla shares, plus many others, are grossly overvalued.
Tesla (TSLA) is just one of eight major large-cap stocks, including health care's West Pharmaceuticals (WST) and Abiomed (ABMD) plus industrial Old Dominion Freight Line (ODFL), trading 18% or more past analysts' 12-month price targets. This is based on an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.
Tesla's blowout quarterly profit justifies some of its 260% stock run-up this year. And it also ups the odds the stock will join the S&P 500. But analysts still think Tesla shares, plus many others, are grossly overvalued.
Tesla (TSLA) is just one of eight major large-cap stocks, including health care's West Pharmaceuticals (WST) and Abiomed (ABMD) plus industrial Old Dominion Freight Line (ODFL), trading 18% or more past analysts' 12-month price targets. This is based on an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.